167 related articles for article (PubMed ID: 34036905)
1. Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer.
Xu W; Ding M; Wang B; Cai Y; Guo C; Yuan C
Curr Med Chem; 2021; 28(42):8800-8809. PubMed ID: 34036905
[TBL] [Abstract][Full Text] [Related]
2. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
Zhang YF; Li CS; Zhou Y; Lu XH
Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer.
YiRen H; YingCong Y; Sunwu Y; Keqin L; Xiaochun T; Senrui C; Ende C; XiZhou L; Yanfan C
Mol Cancer; 2017 Nov; 16(1):174. PubMed ID: 29162158
[TBL] [Abstract][Full Text] [Related]
4. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
Yan L; Zhang J; Guo D; Ma J; Shui SF; Han XW
Int J Oncol; 2019 Jan; 54(1):7-16. PubMed ID: 30387833
[TBL] [Abstract][Full Text] [Related]
5. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in Gastric Cancer.
Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
Xi Z; Si J; Nan J
Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
9. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
11. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.
Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K
Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518
[TBL] [Abstract][Full Text] [Related]
12. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract][Full Text] [Related]
14. The Role of LncRNA NEAT1 in Gastric Cancer: Tumor Development and Potential Therapeutic Target.
Zhang Y; Wen Y
Curr Pharm Des; 2023; 29(28):2213-2222. PubMed ID: 37779403
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
Li H; He C; Wang X; Wang H; Nan G; Fang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
17. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
18. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
[TBL] [Abstract][Full Text] [Related]
19. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]